These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
227 related items for PubMed ID: 8347952
41. Renal capsular hemangioma: unusual MR findings. Rueckforth J, Rhode D, Baba H, Adam G. J Comput Assist Tomogr; 1995; 19(5):817-8. PubMed ID: 7560334 [No Abstract] [Full Text] [Related]
42. Cervical carcinoma: comparison of standard and pharmacokinetic MR imaging. Hawighorst H, Knapstein PG, Weikel W, Knopp MV, Schaeffer U, Brix G, Essig M, Hoffmann U, Zuna I, Schönberg S, van Kaick G. Radiology; 1996 Nov; 201(2):531-9. PubMed ID: 8888254 [Abstract] [Full Text] [Related]
43. Ovarian lesions: detection and characterization with gadolinium-enhanced MR imaging at 1.5 T. Stevens SK, Hricak H, Stern JL. Radiology; 1991 Nov; 181(2):481-8. PubMed ID: 1924792 [Abstract] [Full Text] [Related]
44. Small (<4 cm) renal mass: differentiation of angiomyolipoma without visible fat from renal cell carcinoma utilizing MR imaging. Sasiwimonphan K, Takahashi N, Leibovich BC, Carter RE, Atwell TD, Kawashima A. Radiology; 2012 Apr; 263(1):160-8. PubMed ID: 22344404 [Abstract] [Full Text] [Related]
45. Chronic pancreatitis: MR imaging features before and after administration of gadopentetate dimeglumine. Semelka RC, Shoenut JP, Kroeker MA, Micflikier AB. J Magn Reson Imaging; 1993 Apr; 3(1):79-82. PubMed ID: 8428105 [Abstract] [Full Text] [Related]
48. Renal masses: quantitative analysis of enhancement with signal intensity measurements versus qualitative analysis of enhancement with image subtraction for diagnosing malignancy at MR imaging. Hecht EM, Israel GM, Krinsky GA, Hahn WY, Kim DC, Belitskaya-Levy I, Lee VS. Radiology; 2004 Aug; 232(2):373-8. PubMed ID: 15215544 [Abstract] [Full Text] [Related]
49. Hepatic lesion detection at MR imaging: a comparative study with four sequences. Blakeborough A, Ward J, Wilson D, Griffiths M, Kajiya Y, Guthrie JA, Robinson PJ. Radiology; 1997 Jun; 203(3):759-65. PubMed ID: 9169701 [Abstract] [Full Text] [Related]
51. Cholangiocarcinoma: spectrum of appearances on MR images using current techniques. Worawattanakul S, Semelka RC, Noone TC, Calvo BF, Kelekis NL, Woosley JT. Magn Reson Imaging; 1998 Nov; 16(9):993-1003. PubMed ID: 9839983 [Abstract] [Full Text] [Related]
52. Pretherapeutic staging of hypopharyngeal carcinoma. Clinical findings, computed tomography, and magnetic resonance imaging compared with histopathologic evaluation. Zbären P, Becker M, Läng H. Arch Otolaryngol Head Neck Surg; 1997 Sep; 123(9):908-13. PubMed ID: 9305239 [Abstract] [Full Text] [Related]
53. Renal lymphoma: demonstration by MR imaging. Semelka RC, Kelekis NL, Burdeny DA, Mitchell DG, Brown JJ, Siegelman ES. AJR Am J Roentgenol; 1996 Apr; 166(4):823-7. PubMed ID: 8610558 [Abstract] [Full Text] [Related]
54. Suspect breast lesions: findings at dynamic gadolinium-enhanced MR imaging correlated with mammographic and pathologic features. Stomper PC, Herman S, Klippenstein DL, Winston JS, Edge SB, Arredondo MA, Mazurchuk RV, Blumenson LE. Radiology; 1995 Nov; 197(2):387-95. PubMed ID: 7480682 [Abstract] [Full Text] [Related]
55. MR diagnosis of hepatic metastases from neuroendocrine tumors versus hemangiomas: relative merits of dynamic gadolinium chelate-enhanced gradient-recalled echo and unenhanced spin-echo images. Soyer P, Gueye C, Somveille E, Laissy JP, Scherrer A. AJR Am J Roentgenol; 1995 Dec; 165(6):1407-13. PubMed ID: 7484575 [Abstract] [Full Text] [Related]
56. Use of gadolinium-DTPA-enhanced MRI to characterize renal mass in patient with renal insufficiency. Terens WL, Gluck R, Golimbu M, Rofsky NM. Urology; 1992 Aug; 40(2):152-4. PubMed ID: 1502753 [Abstract] [Full Text] [Related]
57. Renal lesion characterization with gadolinium-enhanced MR imaging: efficacy and safety in patients with renal insufficiency. Rofsky NM, Weinreb JC, Bosniak MA, Libes RB, Birnbaum BA. Radiology; 1991 Jul; 180(1):85-9. PubMed ID: 2052729 [Abstract] [Full Text] [Related]
58. [Characterization and staging of renal tumors: significance of MRI diagnostics]. Kalinka A, Gerlach A, Arlart IP, Günes N, Hauser TK, Würstlin S, Bosse A. Rofo; 2006 Mar; 178(3):298-305. PubMed ID: 16508837 [Abstract] [Full Text] [Related]
59. Germinoma originating in the basal ganglia and thalamus: MR and CT evaluation. Higano S, Takahashi S, Ishii K, Matsumoto K, Ikeda H, Sakamoto K. AJNR Am J Neuroradiol; 1994 Sep; 15(8):1435-41. PubMed ID: 7985560 [Abstract] [Full Text] [Related]
60. Pelvic lesions in patients with treated cervical carcinoma: efficacy of pharmacokinetic analysis of dynamic MR images in distinguishing recurrent tumors from benign conditions. Hawighorst H, Knapstein PG, Schaeffer U, Knopp MV, Brix G, Hoffmann U, Zuna I, Essig M, van Kaick G. AJR Am J Roentgenol; 1996 Feb; 166(2):401-8. PubMed ID: 8553955 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]